Cornell researchers have discovered a way to open one of the major barriers to the brain, called the blood brain barrier (BBB), which prevents the entry of therapies to treat brain disorders, such as Alzheimer’s disease.
The finding also has implications for treating all chemotherapy-resistant cancers.
For a century now, a major challenge in the treatment of diseases of the brain has been discovering how to safely deliver drugs across the BBB. The BBB is composed of a layer of specialized cells, called endothelial cells, which line the brain’s blood vessels and safeguard the brain from unwanted substances. These cells also selectively allow entry of molecules needed for brain function, such as amino acids, oxygen, glucose and water.
Cornell researchers report that an FDA-approved drug called Lexiscan, which is used in heart imaging, activates receptors – called adenosine receptors – that are expressed on these BBB cells.
“We can open the BBB for a brief window of time, long enough to deliver therapies to the brain, but not too long so as to harm the brain. We hope in the future, this will be used to treat many types of neurological disorders,” said Margaret Bynoe, associate professor in the Department of Microbiology and Immunology in Cornell’s College of Veterinary Medicine. Bynoe is senior author of the study appearing April 4 in The Journal of Clinical Investigation. Do-Geun Kim, now a postdoctoral associate in Bynoe’s lab, is the paper’s first author.
The researchers were able to deliver chemotherapy drugs into the brains of mice, as well as large molecules, like an antibody that binds to Alzheimer’s disease plaques, according to the paper.
To test whether this drug delivery system has application to the human BBB, the lab engineered a BBB model using human primary brain endothelial cells. They observed that Lexiscan opened the engineered BBB in a manner similar to its actions in mice.
Bynoe and Kim discovered that a protein called P-glycoprotein is highly expressed on brain endothelial cells and blocks the entry of most drugs delivered to the brain. Lexiscan acts on one of the adenosine receptors expressed on BBB endothelial cells specifically activating them. They showed that Lexiscan down-regulates P-glycoprotein expression and function on the BBB endothelial cells. It acts like a switch that can be turned on and off in a time dependent manner, which provides a measure of safety for the patient.
“We demonstrated that down-modulation of P-glycoprotein function coincides exquisitely with chemotherapeutic drug accumulation” in the brains of mice and across an engineered BBB using human endothelial cells, Bynoe said. “The amount of chemotherapeutic drugs that accumulated in the brain was significant.”
In addition to P-glycoprotein’s role in inhibiting foreign substances from penetrating the BBB, the protein is also expressed by many different types of cancers and makes these cancers resistant to chemotherapy.
“This finding has significant implications beyond modulation of the BBB,” Bynoe said. “It suggests that in the future, we may be able to modulate adenosine receptors to regulate P-glycoprotein in the treatment of cancer cells resistant to chemotherapy.”
Because Lexiscan is an FDA-approved drug, ”the potential for a breakthrough in drug delivery systems for diseases such as Alzheimer’s disease, Parkinson’s disease, autism, brain tumors and chemotherapy-resistant cancers is not far off,” Bynoe said.
Another advantage is that these molecules (adenosine receptors and P-glycoprotein are naturally expressed in mammals. “We don’t have to knock out a gene or insert one for a therapy to work,” Bynoe said.
The Latest on: Blood brain barrier
via Google News
The Latest on: Blood brain barrier
- Dissecting and rebuilding the glioblastoma microenvironment with engineered materialson August 16, 2019 at 8:33 am
such as the blood–brain barrier and axonal tracts. Biomaterials can be applied to develop synthetic models of the GBM TME to mimic physiological and pathophysiological features of the brain, including ...
- QUANTUM GENOMICS Is Making Significant Advances in the Development of a New, Groundbreaking Drug to Help with Treatment-resistant Chronic Hypertensionon August 16, 2019 at 7:42 am
Firibastat works by crossing the blood-brain barrier and modulating the brain renin-angiotensin system (RAS). RAS is a hormone system that controls blood pressure in part by modulating dilation ...
- Bioasis Strengthens Senior Management Team with Appointment of Caroline Dircks, Ph.D. as Chief Operating Officeron August 15, 2019 at 1:05 pm
--(Business Wire)--BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI), ), a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB 3 TM platform technology for the ...
- 3D Model of Alzheimer’s Shows Role of Blood-Brain Barrier in Disease Progressionon August 14, 2019 at 2:14 pm
MIT engineers have developed a tissue model that mimics beta-amyloid’s effects on the blood-brain barrier. Beta-amyloid plaques—the protein aggregates that form in the brains of Alzheimer’s ...
- Nanocapsule reaches cancer that has spread to central nervous system in miceon August 14, 2019 at 2:11 pm
Now, UCLA researchers have developed a drug delivery system that breaks through the blood-brain barrier in order to reach and treat cancer that has spread to the central nervous system.
- Blood-brain barrier role in Alzheimer’s patients revealed by tissue modelon August 13, 2019 at 8:35 am
A new study has found that damage caused by Alzheimer’s allows toxins to enter the brain, further harming neurons. The blood-brain barrier — the normally tight border that prevents harmful molecules ...
- Tissue model of Alzheimer's mimics beta-amyloid's effects on blood-brain barrieron August 13, 2019 at 3:05 am
Beta-amyloid plaques, the protein aggregates that form in the brains of Alzheimer's patients, disrupt many brain functions and can kill neurons. They can also damage the blood-brain barrier — the ...
- Air Pollution Gets Into Your Brain, and Scientists Want to Know What It's Doing to Youon August 6, 2019 at 12:50 pm
Fine particulate matter is small enough to freely cross the blood-brain barrier that keeps out larger toxins. Alternatively, if inhaled through the nose, the fine particles can get to the brain ...
- Study explores blood-brain barrier leakage in CNS infectionson August 6, 2019 at 3:04 am
A new study published in the journal mBio shines light on the breakdown of the blood-brain barrier (BBB) that occurs during many infections of the central nervous system. The findings implicate ...
- New drug could be used for future treatments of brain tumorson August 5, 2019 at 11:30 pm
and the lack of penetration through the blood brain barrier - IP1867B was shown to be effective at avoiding all of these limiting factors. In a new study, published in the journal Cancer Letters, ...
via Bing News